TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report
/PRNewswire/ -- TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of the European Multiple Myeloma (MM) Real-World...
Source: prnewswire.com